|
Vitamin D inhibited breast cancer stem cells through Wnt/β-catenin signaling pathway
SHA Yutong, HUANG Jiaming, LU Zhenping, LIANG Huan, ZHENG Zongmei, YANG Xuepan, SHI Hongfei, ZHU Mingming
2019, 11 (4):
297-302.
doi: 10.3969/j.issn.1674-5671.2019.04.05
Objective To explore the effect of Vitamin D on the activity of breast cancer stem cells and its possible mechanism. Methods The effects of different concentrations(1 μmol/L, 5 μmol/L, 10 μmol/L and 20 μmol/L) of Vitamin D on the viability of breast cancer SUM159 cells were detected by MTT assay. The breast cancer stem cells CSCSUM159 were enriched in suspension culture in serum-free medium to analyze the effect of Vitamin D on the activity of breast cancer stem cells. Western blot and Real-time qPCR were used to detect the expression of the breast cancer stem cell markers CD133, CD44, Oct-4 and Nanog,and Wnt/β-catenin signaling pathway-related genes p-GSK-3β, β-catenin, c-Myc and cyclin-D1. Results MTT assay showed that 1 μmol/L, 5 μmol/L, 10 μmol/L and 20 μmol/L Vitamin D inhibited the viability of breast cancer SUM159 cells significantly(P<0.01). Serum-free medium culture could effectively enrich breast cancer stem cells CSCSUM159. Vitamin D reduced the number and size of SUM159 tumorsphere. Western blot and Real-time qPCR showed that Vitamin D down-regulated the protein expression of CD133, CD44 and Nanog and inhibited the protein expression levels of p-GSK-3β, β-catenin and c-Myc,and down-regulated the mRNA expression of β-catenin,c-Myc and cyclin-D1 in breast cancer stem cell CSCSUM159(P<0.05). Conclusion Vitamin D can inhibit the activity of breast cancer stem cells, which may be related to its regulation of Wnt/β-catenin signaling pathway.
Related Articles |
Metrics
|